284
Views
9
CrossRef citations to date
0
Altmetric
Original Research

308-nm Excimer Laser Plus Platelet-Rich Plasma for Treatment of Stable Vitiligo: A Prospective, Randomized Case–Control Study

, &
Pages 461-467 | Published online: 23 Jul 2020

References

  • Bergqvist C, Ezzedine K. Vitiligo: a review [published online ahead of print, 2020 Mar 10]. Dermatology. 2020;1–22. doi:10.1159/000506103
  • Abdel-Malek ZA, Jordan C, Ho T, Upadhyay PR, Fleischer A, Hamzavi I. The enigma and challenges of vitiligo pathophysiology and treatment [published online ahead of print, 2020 Mar 21]. Pigment Cell Melanoma Res. 2020. doi:10.1111/pcmr.12878
  • Li L, Liang Y, Zhang D, et al. The 308-nm excimer laser stimulates melanogenesis via the wnt/β-Catenin signaling pathway in B16 cells. J Dermatol Treat. 2019;21:1–5.
  • Wu Y, Sun Y, Qiu L, et al. A multicentre, randomized, split face and/or neck comparison of 308-nm excimer laser and 0.1% tacrolimus ointment for stable vitiligo plus intramuscular slow-releasing betamethasone for active vitiligo. Br J Dermatol. 2019;181(1):210–211. doi:10.1111/bjd.1763030644997
  • Li L, Liang Y, Hong J, Lan L, Xiao H, Xie Z. The effectiveness of topical therapy combined with 308-nm excimer laser on vitiligo compared to excimer laser monotherapy in pediatric patients. Pediatr Dermatol. 2019;36(1):e53–e55. doi:10.1111/pde.1372630520111
  • Wang X, Liu GY. Progress of 308 nm excimer laser combined with other methods in the treatment of vitiligo. Chin J Dermatol. 2017;50(9):695–697.
  • Baltás E, Nagy P. Repigmentation of localized vitiligo with the xenon chloride laser. Br J Dermatol. 2001;144(6):1266–1267. doi:10.1046/j.1365-2133.2001.04248.x11422057
  • Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308 nm excimer laser: a pilot study. J Am Acad Dermatol. 2002;46:727–731. doi:10.1067/mjd.2002.12135712004315
  • Mehraban S, Feily A. 308 nm excimer laser in dermatology. J Lasers Med Sci. 2014;5:8–12.25606333
  • Zhang C, Zhou L, Huang J, Shi W. A combination of Yiqiqubai granule and 308-nm excimer laser in treatment of segmental vitiligo: a prospective study of 233 patients. J Dermatol Treat. 2017;28(7):668–671. doi:10.1080/09546634.2017.1303570
  • Abuaf OK, Yildiz H, Baloglu H, Bilgili ME, Simsek HA, Dogan B. Histologic evidence of new collagen formulation using platelet rich plasma in skin rejuvenation: a prospective controlled clinical study. Ann Dermatol. 2016;28(6):718–724. doi:10.5021/ad.2016.28.6.71827904271
  • Charneux L, Demoulin C, Vanderthomment M, et al. Platelet-rich plasma (PRP) and disc lesions: a review of the literature. Neurochirurgie. 2017;63(6):473–477. (in French). doi:10.1016/j.neuchi.2017.06.00229128087
  • Liu-Bryan R, Terkeltaub R. Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol. 2015;11(1):35–44. doi:10.1038/nrrheum.2014.16225266449
  • Badran KW, Sand JP. Platelet-rich plasma for hair loss: review of methods and results. Facial Plast Surg Clin North Am. 2018;26(04):469–485. doi:10.1016/j.fsc.2018.06.00830213428
  • Xu AE, Gao TW. Consensus on diagnosis and treatment of vitiligo (2018). Chin J Dermatol. 2018;51(4):247–250.
  • Njoo MD, Das PK, Bos JD, Westerhof W. Association of the Kobner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 1999;135(4):407–413. doi:10.1001/archderm.135.4.40710206047
  • Xiang W, Xu A, Xu J, Bi Z, Shang Y, Ren Q. In vivo confocal laser scanning microscopy of hypopigmented macules: a preliminary comparison of confocal images in vitiligo, nevus depigmentosus and postinflammatory hypopigmentation. Lasers Med Sci. 2010;25(4):551–558. doi:10.1007/s10103-010-0764-220180143
  • Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–871. doi:10.1001/archderm.1988.016700600150083377516
  • Yuan J, Chen H, Yan R, et al. Fractional CO2 lasers contribute to the treatment of stable non-segmental vitiligo. Eur J Dermatol. 2016;26(6):592–598. doi:10.1684/ejd.2016.287527818365
  • Abdelghani R, Ahmed NA, Darwish HM. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: a prospective, randomized comparative trial. J Cosmet Dermatol. 2018;17(3):365–372. doi:10.1111/jocd.1239728834191
  • Yuan T, Guo S, Han P, et al. Applications of leukocyte and platelet -rich plasma (L-PRP) in trauma surgery. Curr Pharm Biotechnol. 2012;13(7):1173–1184. doi:10.2174/13892011280062444521740374
  • Kim DH, Je YJ, Kim CD, et al. Can platelet-rich plasma be used for skin rejuvenation? Evaluation of effects of platelet-rich plasma on human dermal fibroblast. Ann Dermatol. 2011;23:424–431. doi:10.5021/ad.2011.23.4.42422148008
  • Ibrahim ZA, El-Ashmawy AA, Shora OA. Therapeutic effect of microneedling and autologous platelet rich plasma in the treatment of atrophic scars: a randomized study. J Cosmet Dermatol. 2017;16(3):388–399. doi:10.1111/jocd.1235628504480
  • Kumaran MS. Platelet-rich plasma in dermatology: boon or a bane? Indian J Dermatol Venereol Leprol. 2014;80(1):5–14. doi:10.4103/0378-6323.12546724448117
  • Khattab FM, Abdelbary E, Fawzi M. Evaluation of combined excimer laser and platelet‐rich plasma for the treatment of nonsegmental vitiligo: A prospective comparative study. J Cosmet Dermatol. 2020; 19(4): 869–877. doi:10.1111/jocd.v19.431541597
  • Osinubi O, Grainge MJ, Hong L, et al. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2018;178(4):863–878. doi:10.1111/bjd.1604928991357
  • Goldinger SM, Dummer R, Schmid P, Burg G, Seifert B, Läuchli S. Combination of 308 nm xenon chloride excimer laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol. 2007;21:504–508. doi:10.1111/j.1468-3083.2006.02016.x17373978
  • Oh SH, Kim T, Jee H, Do JE, Lee JH. Combination treatment of non-segmental vitiligo with a 308-nm xenon chloride excimer laser and topical high-concentration tacalcitol: a prospective, single-blinded, paired, comparative study. J Am Acad Dermatol. 2011;65:428–430. doi:10.1016/j.jaad.2010.12.00721763570
  • Choi CP, Kim YI, Lee JW, Lee MH. The effect of narrowband ultraviolet B on the expression of matrix metalloproteinase-1, transforming growth factor-beta1 and type I collagen in human skin fibroblasts. Clin Exp Dermatol. 2007;32:180–185. doi:10.1111/j.1365-2230.2006.02309.x17137474
  • Cario-Andre M, Pain C, Gauthier Y, Casoli V, Taoeb A. In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Res. 2006;19:434–442. doi:10.1111/j.1600-0749.2006.00326.x16965272
  • Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res. 2004;17:96–100. doi:10.1111/j.1600-0749.2003.00126.x15016298
  • Dey-Rao R, Sinha AA. Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo. Genes Immun. 2016;17:30–45. doi:10.1038/gene.2015.4826562080
  • El-Sharkawy H, Kantarci A, Deady J, et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol. 2007;78:661–669. doi:10.1902/jop.2007.06030217397313
  • Devereaux J, Nurgali K, Kiatos D, Sakkal S, Apostolopoulos V. Effects of platelet-rich plasma and platelet-poor plasma on human dermal fibroblasts. Maturitas. 2018;117:34–44. doi:10.1016/j.maturitas.2018.09.00130314559